{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:54:26Z","timestamp":1781830466284,"version":"3.54.5"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ymthe.2026.03.036","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T21:35:44Z","timestamp":1776288944000},"page":"2544-2546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A molecular makeover of laminin-\u03b14 with linker proteins to mimic the function of laminin-\u03b12 for the treatment of LAMA2-CMD"],"prefix":"10.1016","volume":"34","author":[{"given":"Hailey J.","family":"Hermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannen","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9228-5258","authenticated-orcid":false,"given":"Dean J.","family":"Burkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.03.036_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3233\/JND-221552","article-title":"Estimating the Prevalence of LAMA2 Congenital Muscular Dystrophy using Population Genetic Databases","volume":"10","author":"Lake","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.ymthe.2026.03.036_bib2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ng1095-216","article-title":"Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy","volume":"11","author":"Helbling-Leclerc","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2026.03.036_bib3","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1016\/j.ymthe.2026.01.041","article-title":"Dual AAV gene therapy using laminin-linking proteins ameliorates muscle and nerve defects in LAMA2-related muscular dystrophy","volume":"34","author":"Reinhard","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.03.036_bib4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00018-004-4510-4","article-title":"Congenital muscular dystrophy: molecular and cellular aspects","volume":"62","author":"Jimenez-Mallebrera","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2026.03.036_bib5","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/hmg\/ddx083","article-title":"Impaired fetal muscle development and JAK-STAT activation mark disease onset and progression in a mouse model for merosin-deficient congenital muscular dystrophy","volume":"26","author":"Nunes","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.03.036_bib6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/35095054","article-title":"An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy","volume":"413","author":"Moll","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.03.036_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/glia.1075","article-title":"Schwann cell myelination occurred without basal lamina formation in laminin alpha2 chain-null mutant (dy3K\/dy3K) mice","volume":"35","author":"Nakagawa","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.ymthe.2026.03.036_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41586-019-1430-x","article-title":"A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene","volume":"572","author":"Kemaladewi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.03.036_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13395-020-00235-4","article-title":"Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD","volume":"10","author":"Barraza-Flores","year":"2020","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ymthe.2026.03.036_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.194581","article-title":"Spatial proteomics reveals recombinant human laminin-111 restores adhesion signaling to laminin-alpha2-deficient muscle","volume":"10","author":"Hermann","year":"2025","journal-title":"JCI Insight"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626002212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626002212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:33:50Z","timestamp":1781829230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626002212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1525001626002212"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.03.036","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A molecular makeover of laminin-\u03b14 with linker proteins to mimic the function of laminin-\u03b12 for the treatment of LAMA2-CMD","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.03.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.01.041","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}